Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc. is not a good growth stock. Ionis Pharmaceuticals, Inc. is not very popular among insiders. Ionis Pharmaceuticals, Inc. is a mediocre stock to choose.

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic dr...

News

IONS Crosses Below Key Moving Average Level

Market News Video In trading on Tuesday, shares of Ionis Pharmaceuticals Inc (IONS) crossed below their 200 day moving average of 45.96, changing hands as low as 42.91 per share. Ionis Pharmaceuticals Inc...\n more…

Ionis Pharmaceuticals 11.5M share Spot Secondary priced at $43.50

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Ionis announces pricing of $500.3 million public offering

PR Newswire Ionis announces pricing of $500.3 million public offering Ionis announces pricing of $500.3 million public offering PR Newswire CARLSBAD, Calif., Sept. 9, 2024 CARLSBAD, Calif., Sept. 9, 2024...\n more…

Ionis Pharmaceuticals announces $500M common stock offering

Ionis announces proposed public offering of common stock

PR Newswire Ionis announces proposed public offering of common stock Ionis announces proposed public offering of common stock PR Newswire CARLSBAD, Calif., Sept. 9, 2024 CARLSBAD, Calif., Sept. 9, 2024...\n more…